Klinique Med (Thailand) Analysis
| KLINIQ Stock | 31.50 0.75 2.44% |
The Klinique Med is overvalued with Real Value of 27.3 and Hype Value of 31.5. The main objective of Klinique Med stock analysis is to determine its intrinsic value, which is an estimate of what The Klinique Med is worth, separate from its market price. There are two main types of Klinique Med's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Klinique Med's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Klinique Med's stock to identify patterns and trends that may indicate its future price movements.
The Klinique Med stock is traded in Thailand on Thailand Exchange, with the market opening at 10:00:00 and closing at 16:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Thailand. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Klinique Med's ongoing operational relationships across important fundamental and technical indicators.
Klinique |
Klinique Stock Analysis Notes
About 74.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years. To find out more about The Klinique Med contact Apiruj Thongwattana at 66 80 000 9800 or learn more at https://www.theklinique.com.Klinique Med Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Klinique Med's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding The Klinique Med or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Klinique Med generated a negative expected return over the last 90 days | |
| About 74.0% of the company outstanding shares are owned by corporate insiders |
Klinique Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.81 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Klinique Med's market, we take the total number of its shares issued and multiply it by Klinique Med's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Klinique Profitablity
Klinique Med's profitability indicators refer to fundamental financial ratios that showcase Klinique Med's ability to generate income relative to its revenue or operating costs. If, let's say, Klinique Med is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Klinique Med's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Klinique Med's profitability requires more research than a typical breakdown of Klinique Med's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.13 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.17 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.17. Technical Drivers
As of the 28th of November, Klinique Med secures the Risk Adjusted Performance of (0.07), market risk adjusted performance of 0.6396, and Standard Deviation of 1.87. The Klinique Med technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.Klinique Med Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Klinique Med middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Klinique Med. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Klinique Med Predictive Daily Indicators
Klinique Med intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Klinique Med stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Klinique Med Forecast Models
Klinique Med's time-series forecasting models are one of many Klinique Med's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Klinique Med's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Klinique Med to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Complementary Tools for Klinique Stock analysis
When running Klinique Med's price analysis, check to measure Klinique Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klinique Med is operating at the current time. Most of Klinique Med's value examination focuses on studying past and present price action to predict the probability of Klinique Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klinique Med's price. Additionally, you may evaluate how the addition of Klinique Med to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |